PortfoliosLab logoPortfoliosLab logo

Documentation

Upgrade your plan

First Trust Health Care AlphaDEX Fund (FXH) Sharpe Ratio: 0.98

ETF · Currency in USD · Last updated Jun 24, 2026

FXH is a passive ETF by First Trust tracking the investment results of the StrataQuant Health Care Index. FXH launched on May 8, 2007 and has a 0.61% expense ratio.

FXH's Sharpe Ratio of 0.98 indicates that for each unit of volatility, it generates 0.98 units of excess return above the risk-free rate. The ratio is calculated using historical daily returns over the past 12 months (as of Jun 24, 2026).

Sharpe uses total volatility (standard deviation) which includes both upside and downside price movements, making it useful for comparing risk-adjusted returns across different assets. For how to read this number and when it can mislead, see Sharpe Ratio Explained.

FXH Sharpe Ratio Rank

FXH Sharpe Ratio Rank: 28.529
Below Average

FXH ranks above 28.5% of all investments in our database based on Sharpe Ratio over the past 12 months, indicating below-average returns relative to volatility. Securities are ranked from 0 (worst) to 100 (best).

What moves the rank

  • Strong returns with low total volatility → Higher rank
  • High volatility (both upside and downside) → Lower rank
  • Consistent returns → Higher rank than volatile returns of same magnitude
  • Sharp drawdowns increase volatility → Lower rank

What you can do with this information

  • Returns may not adequately compensate for volatility taken
  • Consider smaller allocation given below-average risk-adjusted profile
  • Explore higher-ranked investments with better consistency
  • Assess whether the volatility profile aligns with your portfolio goals

FXH Sharpe Ratio Market Positioning

The chart shows FXH's Sharpe Ratio relative to all ETFs on our platform, with color zones indicating percentile rankings. Higher ratios indicate better risk-adjusted returns.

  • Red zone (bottom 25%): 0.83 or lower
  • Yellow zone (middle 50%): 0.83 to 2.16
  • Green zone (top 25%): 2.16 or higher
  • Top 1%: 7.01+
  • Median: 1.57 — half of all investments score higher

How it compares to other similar ETFs

The table compares First Trust Health Care AlphaDEX Fund's Sharpe Ratio with other ETFs in the Health & Biotech Equities category across multiple time periods, showing how FXH's risk-adjusted performance compares to similar funds.

Data shows 1-, 5-, and 10-year periods, plus each fund's all-time average, as of Jun 24, 2026.

SymbolName1Y Sharpe Ratio5Y Sharpe Ratio10Y Sharpe RatioAll Time Sharpe Ratio
BBCVirtus LifeSci Biotech Clinical Trials ETF4.36
SBIOALPS Medical Breakthroughs ETF3.22
XBISPDR S&P Biotech ETF3.02
LFSCF/m Emerald Life Sciences Innovation ETF2.85
IBRNiShares Neuroscience and Healthcare ETF2.80
IHEiShares U.S. Pharmaceuticals ETF2.74
PJPInvesco Dynamic Pharmaceuticals ETF2.71
FTXHFirst Trust Nasdaq Pharmaceuticals ETF2.61
XPHSPDR S&P Pharmaceuticals ETF2.55
CANCTema Oncology ETF2.52
FXHFirst Trust Health Care AlphaDEX Fund0.98

S&P 500 Index

How to choose period

Historical Sharpe Ratio

The chart shows FXH's rolling Sharpe ratio over time compared to your chosen benchmark. Rising trends indicate improving returns relative to total volatility, while declining trends may signal deteriorating risk-adjusted performance or increased volatility. Use multiple timeframes to distinguish short-term fluctuations from long-term patterns.

Identify market cycles by observing when FXH consistently outperforms (line above benchmark), underperforms (below benchmark), or aligns with the benchmark.

Loading charts...

Sharpe Ratio Calculator

How does FXH fit in your portfolio?

Add your other holdings to see your portfolio's Sharpe Ratio and find out.

Analyze Your Portfolio